Atomoxetine for Treating Attention Deficit Hyperactivity Disorder in Young Children - Related Studies

Atomoxetine for Treating Attention Deficit Hyperactivity Disorder in Young Children

This study is ongoing, but not recruiting participants.

Study NCT00254462. Last updated on August 28, 2008. Information provided by National Institute of Mental Health (NIMH)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Additional conditions recognized in this trial
		Attention Deficit Disorder with Hyperactivity
		Disease
		Hyperkinesis

2	More general conditions related to this trial
		Attention Deficit and Disruptive Behavior Disorders
		Dyskinesias
		Mental Disorders
		Mental Disorders Diagnosed in Childhood
		Nervous System Diseases
		Neurologic Manifestations
		Pathologic Processes
		Signs and Symptoms

3	Interventions listed in this trial
		Atomoxetine
		Placebo
		Parent Training

4	More general drug interventions related to this trial
		Adrenergic Agents
		Adrenergic Uptake Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Neurotransmitter Agents
		Neurotransmitter Uptake Inhibitors
		Pharmacologic Actions
		Physiological Effects of Drugs

5	Sponsors listed in this trial
		National Institute of Mental Health (NIMH)